-The Hindu Business Line Agreement between Viatris, MedAccess and TBA to slash cost by 34 per cent on pretomanid A new agreement among drugmaker Viatris, MedAccess, and TB Alliance looks to reduce the price of pretomanid, a drug used to treat multidrug-resistant Tuberculosis, by 34 per cent. The agreement will help expand access to this critical new treatment in more than 140 countries, including those with the highest TB burden, said a joint...
More »SEARCH RESULT
Total Matching Records found : 383
Is India on track in reducing TB incidence and deaths?
Like the fight against poverty and hunger, the progress made by mankind against Tuberculosis (TB) in the years up to 2019 has either slowed, stalled, or reversed, and global TB targets are off track due to the COVID-19 pandemic. Globally, although the reported number of people newly diagnosed with TB decreased from 7.1 million to 5.8 million between 2019 and 2020, the number went up to 6.4 million in 2021....
More »As COVID-19 Dips, Tuberculosis is the Most Lethal Infectious Disease Again -Mohd. Imran Khan
-Newsclick.in As per recent estimates, TB is killing approximately three times as many people as COVID-19 every day. Patna: Tuberculosis is one of the most lethal infectious diseases on the rise after the fears and deaths due to the COVID-19 pandemic have come down. As per the latest report by TB Alliance, a not-for-profit organisation, HIV/AIDS is back in second place, and TB is in first place. “A few years back, Tuberculosis overtook...
More »COVID-19: Over 5 Lakh People in India Missed or Delayed TB Diagnosis in 2020
-PTI/ Newsclick.in Globally, over 1.5 million people in 45 high-burden countries missed or delayed Tuberculosis diagnosis in the first year of the pandemic, says study. New Delhi: Over five lakh people in India are estimated to have had a missed or delayed Tuberculosis diagnosis in 2020 due to the disruptions caused by the COVID-19 pandemic, according to a study. The researchers found that over 1.5 million people in 45 high-burden countries had a...
More »Despite increased budget, estimated TB deaths rise in India: WHO's Global TB Report 2022 - Neetu Chandra Sharma
-BusinessToday.in This is the first time in many years an increase has been reported in the number of people falling ill with TB and drug-resistant TB, it said. Despite an increase in the budget to tackle Tuberculosis (TB), the interim estimated number of deaths due to the infectious disease in India rose by 10 per cent, from 500,000 in 2020 to 505,000 in 2021, noted the Global TB Report 2022 released by...
More »
